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Abstract
Cholera remains a significant public health challenge in many sub-Saharan countries including Kenya. We have
performed a combination of phylogenetic and phenotypic analysis based on whole genome DNA sequences derived
from 40 environmental and 57 clinical V. cholerae from different regions of Kenya isolated between 2005 and 2010.
Some environmental and all clinical isolates mapped back onto wave three of the monophyletic seventh pandemic V.
cholerae El Tor phylogeny but other environmental isolates were phylogenetically very distinct. Thus, the genomes of
the Kenyan V. cholerae O1 El Tor isolates are clonally related to other El Tor V. cholerae isolated elsewhere in the
world and similarly harbour antibiotic resistance-associated STX elements. Further, the Kenyan O1 El Tor isolates fall
into two distinct clades that may have entered Kenya independently.
Citation: Kiiru J, Mutreja A, Mohamed AA, Kimani RW, Mwituria J, et al. (2013) A Study on the Geophylogeny of Clinical and Environmental Vibrio
cholerae in Kenya. PLoS ONE 8(9): e74829. doi:10.1371/journal.pone.0074829
Editor: Igor Mokrousov, St. Petersburg Pasteur Institute, Russian Federation
Received May 21, 2013; Accepted August 6, 2013; Published September 16, 2013
Copyright: © 2013 Kiiru et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by The Wellcome Trust grant 098051 and UBS-Optimus Grant 70:493. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
* E-mail: skariuki@kemri.org
☯ These authors contributed equally to this work.
Introduction
Cholera, caused by the bacterium Vibrio cholerae, is still a
common disease in many parts of the world where public
health infrastructure is compromised. Significantly, although the
Bay of Bengal is traditionally associated with the origin of
pandemic cholera, 66% of the all cases reported between 1995
and 2005 were in sub-Saharan countries (http://www.who.int/
cholera/statistics/en) [1]. In Kenya, the first official case of
cholera was reported in 1971 [2] and since then at least 18
discrete outbreaks have been documented [3-8]. For instance
from 2000 to 2006, the number of cases notified to the World
Health Organisation (WHO) each year ranged from 816 to
1,157. In 2007, a cumulative total of 625 cases resulting in 35
deaths were reported in four regions; Rift Valley (West Pokot,
Turkana), Coast (Kwale), North Eastern (Garissa, Wajir,
Mandera) and Nyanza (Kisumu, Bondo and Siaya). In addition
from January–April 2008, in the Lake Victoria region (Suba,
Migori, Homabay, Rongo, Siaya, Kisumu, Bondo, Nyando, Kisii
South), outbreaks resulted in 790 cases and 53 deaths. During
the period January 2009-May 2010, cholera was reported in
other regions including the coast with a total of 11,769 cases
and 274 deaths (http://www.who.int/wer/2012/wer8731_32.pdf)
[7,8]. To date, little is known about how the cholera cases in
these different regions are related phylogenetically.
Links between cholera and rainfall, sea surface temperature
and plankton have been reported in regions where this disease
is considered endemic [4,9-12], but the emergence and spread
of cholera within local and national boundaries is not fully
understood. Of the 200 serogroups of V. cholerae only O1 and
O139 are associated with epidemic disease [13]. O1 isolates
can be assigned to two biotypes, known as classical and El
Tor, the latter being responsible for the current global seventh
pandemic [14]. El Tor isolates form a relatively conserved
monophyletic lineage that emerges periodically from foci in the
Bay of Bengal with the potential to spread globally and some
Kenyan V. cholerae El Tor isolates have previously been
mapped back onto this phylogeny [14].
Recent work on Kenyan cholera isolates identified 5 Multi-
Locus Variant Analysis (MLVA) clonal complexes circulating in
Kenya [15]. However, MLVA does not provide a phylogenetic
context and therefore has limited utility in the tracking of
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outbreaks. In this study, we have applied whole genome
sequencing linked to phylogenetic and phenotypic analysis to
characterize both environmental and clinical V. cholerae in
Kenya, providing a countrywide analysis of the phylo-dynamics
of this disease.
Methods
Isolation and characterisation of Vibrio cholerae
Clinical isolates were collected from distinct outbreaks that
occurred in different parts of Kenya from 2005 to 2010 (Figure
S1). The outbreak affected regions were: Busia along the
Ugandan border (elevation 1500 meters, average annual
rainfall 2000 mm); Kisumu on the shore of Lake Victoria
(elevation 1200 meters, average annual rainfall 2000 mm);
Malindi, Kilifi and Kwale along the Kenya’s Indian Ocean coast
(elevation 20 m, average annual rainfall 1050 mm); Nairobi, an
area with high population density of approximately 150,000 and
poor sanitation in the Eastland informal settlements (15 km
east of the city, elevation 1800 m, average annual rainfall 750
mm); Thika town 50 km north of Nairobi (elevation 1800,
average annual rainfall 800 mm); Kakuma near Lake Turkana;
West Pokot and Daadab refugee camps and the adjacent town
of Garissa in northeast Kenya (elevation 0-250 m, annual
rainfall less than 250 mm). In most parts of Kenya, January-
February are dry months, followed by a rainy season from
March-June, the exception for the sites we sampled being
Kakuma, West Pokot and Daadab, which are semi-arid all
year-round. For consistency, a distinct outbreak was defined as
a gap of at least 2 months between the last known cholera
case and a report of a new case in the same location. Archived
isolates were initially subcultured on thiosulphate citrate bile
salts sucrose agar (TCBS) and confirmation of isolate identity
was undertaken by serology using polyvalent, anti-Ogawa, and
anti-Inaba antisera (Denka Seiken, Tokyo, Japan). To test for
haemolysis V. cholerae were grown on 5% sheep blood
nutrient agar plates incubated at 37°C overnight. The presence
of V. cholerae virulence genes specific for classical and El Tor
(ctxAB, ompU, hylA, toxR, zot, tcpA) was analysed using whole
genome sequencing [16].
Environmental Vibrio cholerae were isolated from water,
plant materials and sediments from unprotected boreholes,
wells, permanent and seasonal rivers, ponds and surface
runoffs using methods described by Huq et al. [17]. Along Lake
Victoria, water samples were collected at least 5-10 m from the
shoreline. Similarly, ocean water, plant materials and
sediments were collected along bays, estuaries and beaches
along the Kenyan coastline and from shallow oceanic shelves
of the Indian Ocean. In each sampling site, preference was
given to watering points and places with evidence of human
activity such as washing, bathing, fish landing and sale points.
All samples were transported to the laboratory in an insulated
cool box to maintain a temperature close to that of the water at
each collection site and processed within 24h of collection.
Environmental samples were cultured as follows: 10 ml of each
plant homogenate and sediment sample was enriched in 5 ml
triple strength alkaline peptone water and incubated for 18 h.
Subculture was performed from alkaline peptone water onto
TCBS agar and incubated for 18 h. Yellow mucoid colonies
suspected to be V. cholerae were then further defined using
biochemical tests and confirmed by serology.
These field studies did not involve endangered or protected
species from the sampling sites. No vertebrate animals were
sampled. For sampling materials from individual homes
permission and consent was sought from each owner and we
administered a short questionnaire to obtain information on use
of the water in the home. For sampling along the rivers, ponds
and surface runoff there was no need for any approvals as we
did not sample any plant or animal species. To sample along
Lake Victoria shores and Indian ocean shores, we sought
approval from fisheries department and had technicians from
the department involved in helping to obtain samples in the
respective sites.
Antimicrobial susceptibility testing.  Antimicrobial
susceptibility tests were performed using commercial discs
following manufacturer’s instructions (Oxoid, Basingstoke, UK).
Antimicrobials tested included ampicillin (10 µg), cefuroxime
(30ug), ciprofloxacin (5 µg) and nalidixic acid (30 µg) which
were used for testing susceptibility to the quinolones.
Aminoglycosides used in susceptibility tests included
kanamycin (30 µg), streptomycin (30 µg), and gentamicin
(10 µg). We also tested tetracycline (30 µg), chloramphenicol
(30 µg), furazolidone (50 µg), sulphamethoxazole (25 µg) and
trimethoprim (5.2 µg). Escherichia coli ATCC 25922 was used
as a control for bacterial growth and potency of antibiotic discs.
Susceptibility tests were interpreted using the Clinical and
Laboratory Standards Institute guidelines (2012).
Genome sequencing
Multiplex sequencing libraries of 250 bp insertion size were
created and loaded on the Illumina HiSeq cell to perform 72-
base paired-end sequencing of 96 separate libraries in each
lane. Each library had a unique index tag and after sequencing
this tag sequence information was used for assigning reads to
the individual samples. All the samples achieved an average
coverage of 200x in the regions where SNPs were called. All
the data has been submitted to European Nucleotide Archive
with the accession codes listed in Tables S1 and S2.
Whole genome alignment and detection of SNPs
The 72-base paired-end read data obtained was mapped to
the O1 El Tor reference N16961 (NCBI accession numbers
AE003852 and AE003853) using SMALT (http://
www.sanger.ac.uk/resources/software/smalt) to obtain a whole
genome alignment for all the strains in this study. For SNP
calling, the approach of Harris et al. [18] was used. No SNPs
were called from the reads that either did not map to N16961 or
from the regions that were absent from the N16961 reference
genome. Strict filtering of the SNPs was performed and any
SNP with a quality score less than 30 were excluded. Also, a
SNP was considered true only if it was present in at least 75%
of the reads at any heterogeneously mapped ambiguous sites.
High-density SNP clusters and the possible recombination sites
were excluded using he methodology previously described
[19].
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Phylogenetic Analysis
Default settings of RAxML v0.7.4 [20] were used to estimate
the phylogenetic trees based on all the SNPs recorded against
the genome as explained above. The number of SNPs on each
branch were calculated by reconstructing all the polymorphic
events on the tree using PAML [21]. M66 (accession numbers
CP001233 and CP001234), a pre-seventh pandemic strain and
a well-known out-group for the seventh pandemic strains, was
used to root the final phylogenetic tree [14]. For visualization
and ordering of the nodes, phylogenetic tree reading software
Fig tree (http://tree.bio.ed.ac.uk/software/figtree/) was used.
Comparative Genomics
A multi-contig draft genome was generated for each sample
by assembling the paired end reads using a de-novo genome
assembly program Velvet v0.7.03 [22]. The parameters were
set to give the best kmer size and at least 20X kmer coverage.
Contigs were ordered using Abacas as per the reference
N16961 El Tor complete genome sequence [23,24]. Annotation
was transferred from the reference sequence to each ordered
draft assembly. Artemis Comparison Tool was used for manual
comparison of the assembled genomes [25].
Linear Regression Analysis
The final phylogenetic tree was opened using Path-O-Gen
v1.3 (http://tree.bio.ed.ac.uk/software/pathogen) and the root-
to-tip distance data for each strain was exported to excel. This
data was used to plot a linear regression curve against the year
of isolation of the strain. The R-squared correlation, slope and
p-values were determined using the inbuilt regression package
of R statistical environment.
Bayesian Analysis
The tree was reconstructed and the ancestral or nodal dates
for the Kenyan clade and sub-clades were inferred using the
Bayesian Markov Chain Monte Carlo framework [26]. The final
SNP alignment without recombinant sites was used as the
input dataset for BEAST [26] and the rates of evolution on the
branches of the tree were estimated using a relaxed molecular
clock [27], providing the flexibility for the rates of evolution to
change amongst the branches of the tree. A coalescent
constant population size and a GTR model with gamma
correction was used and the results produced from three
independent chains of 100 million steps each sampled every
10,000 steps to maintain homogeneity. The first 10 million
steps of each chain were binned. The results of the three
chains were combined using Log Combiner, and the maximum
clade credibility tree was generated using Tree Annotator
software in the BEAST package (http://tree.bio.ed.ac.uk/
software/beast/). ESS cut off value of 200 was used for each
parameter and convergence was visually confirmed using
Tracer 1.5 (http://tree.bio.ed.ac.uk/software/tracer).
Ethics Statement.  The protocol for this study was approved
by the Kenya Medical Research Institution Review Board
reference SSC No. 1110 for both clinical and environmental
field and laboratory studies. Relevant permissions and consent
was sought for all field studies including environmental
sampling.
Results and Discussion
Properties of clinical and environmental V. cholerae
In order to undertake a whole genome based phylogenetic
analysis of V. cholerae from Kenya we assembled a collection
of clinical and environmental isolates from different regions of
the country (see Methods for full details of isolation and
phenotypic procedures). In total 57 clinical V. cholerae isolates
were obtained from cases of cholera, and 40 isolates were
collected from environmental sources. The environmental
isolates were derived from nine study sites and from water
ranging from pH 4 to 9.7. The demography of sample sites
ranged from waters with algal blooms to areas where regular
household and farming activities on going (Methods and Table
S2). Water samples, plant materials and sediments from
unprotected boreholes, wells, rivers, and surface runoffs were
collected in the following towns bordering Kenya’s Indian
Ocean coast: Mombasa, Malindi, Kilifi and Kwale. Four sites
were sampled along the shore of Lake Victoria (Kisumu, Siaya,
Homa Bay and Kendu Bay) and in Western Kenya the three
district towns of Busia, Vihiga and Kakamega were also
sampled (Tables S1 and S2).
Serotype and antimicrobial susceptibility testing of
Kenyan isolates
All the Kenyan O1 V. cholerae isolates, whether clinical or
environmentally sourced, were found to subtype serologically
as Inaba, whereas some of the environmental isolates were
non-O1. All clinical isolates were resistant to multiple
antibiotics, including nalidixic acid, trimethoprim,
sulphamethoxazole, streptomycin and furazolidone. In contrast,
66% of the environmental isolates were resistant to
sulphamethoxazole, 15% to furazolidone, 56% to ampicillin and
5% to trimethoprim. Noticeably, all the clinical isolates were
fully susceptible to ampicillin. In addition both clinical and
environmental V. cholerae isolates were also fully susceptible
to tetracycline, cefuroxime, chloramphenicol and ciprofloxacin
(Table S1 and Table S2). This contrasts to some extent with
previous Kenyan studies [28] in which 8% and 3% of clinical
and environmental isolates, respectively, from around Lake
Victoria were resistant to tetracycline. This resistance trend has
some similarities to the picture emerging in endemic areas of
Bangladesh where isolates are now uniformly resistant to
trimethoprim/sulfamethoxazole and furazolidone and resistance
to tetracycline and erythromycin shows temporal fluctuation
with variations from year to year [29]. V. cholerae O1 resistant
to tetracycline have previously been reported in Zambia [28] in
the 1990s, but those isolated from Ethiopia [5] and Somalia
[30] in the same period were susceptible to this antibiotic.
Whole genome sequencing and phylogenetic analysis
DNA prepared from 57 clinical and 40 environmental isolates
(Table S1 and Table S2) were sequenced and the data
generated was compared to previously published V. cholerae
Vibrio cholerae in Kenya
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 sequences taken from Mutreja et al. [14] and Hendriksen et al.
[31]. The initial consensus phylogenetic tree generated from
this data (Figure 1a) showed that 27 of the environmental
isolates clustered well outside of the seventh pandemic lineage
and differed by more than 50,000 SNPs from the reference.
Further, only 49% to 89% of their sequence reads mapped
onto the V. cholerae El Tor reference genome N16961. Thus,
such isolates are clearly distinct from V. cholerae O1 El Tor.
However, significantly, the remaining 13 environmentally
sourced isolates clustered with other O1 El Tor seventh
pandemic isolates and these were also serotypically O1
positive. Additionally, 98% of their sequence reads mapped
onto the N16961 El Tor reference genome, differing by only
~250 SNPs from the reference sequence. The genomes of
these isolates also harboured key signature genomic loci
including VSP-1 and 2 and the SXT multiple antibiotic
resistance associated loci found within wave 3 seventh
pandemic isolates [14]. This data unequivocally confirms that
these V. cholerae O1 isolates are members of the seventh
pandemic V. cholerae El Tor phylogeny as part of wave three
described in Mutreja et al. [14].
The presence of environmental V. cholerae isolates
phylogenetically distinct from the main El Tor lineage is
important. Such isolates may be associated with diarrhoeal
diseases distinct from cholera in the respective local
communities and it would be worth investigating this possibility
further. Additionally, such isolates clearly exist in similar
environments to clinically important V. cholerae El Tor,
Figure 1.  Global and seventh pandemic phylogeny.  1a, a maximum likelihood phylogenetic tree of V. cholerae based on the
SNP differences within the core genome. The 6 major O1 clinical groups are shown in this tree with the 7th pandemic El Tor in blue,
classical lineage in green and other colours are match the colours of strains in Table S2. In red are the environmental non O1/O139
strains from Kenya. The date range on the wave 3 node is the BEAST estimated time when the seventh pandemic wave 3 cholera
entered Kenya. 1b, a maximum likelihood phylogenetic tree of the 7th pandemic lineage of V. cholerae based on the SNP
differences across the whole core genome, excluding likely recombination events. The pre-7th pandemic isolate M66 was used as
an outgroup to root the tree. Blue, green and red branches and the clade cartoon represent wave 1, 2, 3 and Kenyan clade
respectively. 1c, a maximum likelihood phylogenetic sub-tree showing the position of Kenyan sporadic or travel linked clustering
with south Asian strains. All the scales are given as the number of substitutions per variable site.
doi: 10.1371/journal.pone.0074829.g001
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presenting the possibility of genetic recombination and the
exchange of antibiotic resistance determinants between these
phylogenetically distinct populations.
To gain a more detailed understanding of the location of the
El Tor isolates within the El Tor seventh pandemic lineage we
constructed a further genome-wide SNP based phylogenetic
tree (Figure 1b) by filtering out high density SNPs and
removing any variation that could be a consequence of
recombination using the method of Croucher et al. [19]. This
tree was based on 1828 variable sites. Here, 53 O1 serogroup
Kenyan isolates clustered within the wave three of the global
seventh pandemic lineage (Figure 1b), with 49 isolates forming
an exclusive Kenyan clade alongside 17 previously published
Kenyan isolates within the wave three lineage (Figure 1b).
Interestingly, four V. cholerae O1 isolates (KNC231, KNC241,
KNC144 and KNC208) clustered in distinct positions within a
clade of isolates from South Asia (Figure 1c), showing that they
occupy distinct positions within the wave three lineages that
could have been brought into Kenya independently, possibly by
travellers.
To gain further insight into the temporal and spatial
distribution of the Kenyan lineages we reconstructed the tree
and dated all the nodes using Bayesian analysis, which is a
tool for mapping isolates against time. In the temporal-spatial
analysis we were also able to estimate that wave three of the
seventh pandemic entered Kenya around 1988-1991, a
refinement on our previous estimate using fewer Kenyan
isolates (1989-1997) [14]. We then performed a linear
regression analysis on the Kenyan clade by plotting the root-to-
tip distance of each isolate against time of isolation, and this
data showed some consistency with our previous findings that
Kenyan cholera isolates are evolving in a clock-like manner
(Figure 2a, 2b and 2c). By refining this analysis we were able
to further subdivide the dominant Kenyan clade into two sub-
clades, designated KSC1 and KSC2 (Figure 2a). Most of the
isolates collected between 2005 and 2010 cluster within one of
these two sub-clades. The most recent common ancestor for
these two sub-clades was estimated to have emerged between
1993-2002 (Figure 2a).
2a, sub tree from the 7th pandemic maximum likelihood
phylogenetic tree showing the Kenyan clade and its two sub-
clades. The nodal date represents tMRCA of the two sub-
clades. 2b, c show root to tip distances of strains of sub-clades
KSC2 and KSC1 arranged in increasing order of magnitude.
The R2 values and the linear regression curves are based on
root to tip distance vs. time (years) on vertical and horizontal
axes respectively. The colours of the strains in 2a and bars in
2b, c represent the locations where the sample was collected.
The root to tip distance for strains from Djibouti and Tanzania
in KSC1 are not provided in 2c.We found some evidence of
regional clustering for clinical isolates within sub-clades KSC1
and KSC2 (Figure 2b and 2c). For example, with few
Figure 2.  Phylogeny of Kenyan strains showing the two subclades.  
doi: 10.1371/journal.pone.0074829.g002
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exceptions, isolates from the Nairobi region fell within the
KSC1 sub-clade while most isolates (clinical and O1-positive
environmental) from the Indian Ocean coast region (Mombasa,
Msambweni, Kwale and Malindi) fell within KSC2, as did those
from Busia on the Kenya-Uganda border. Other isolates from
the Lake Victoria region of Kisumu and Sio-Port clustered in
KSC1 whilst isolates from the Homa-Bay area were distributed
in both KSC1 and KSC2. The isolates from the semi-arid region
of West Pokot in Northern Kenya were also distributed in both
the sub-clades, as were those from environmental sources
near Lake Victoria (Figure 2b and c). There was a strong
correlation between root-to-tip distance and time for KSC2 (R2
= 0.8). The phylo-geographic analysis of KSC2 is consistent
with the notion that cholera may emerge from in and around
Lake Victoria and spread to the central and eastern parts of
Kenya (Figure 2b). However, the same correlation for KSC1
was weak (R2 = 0.2) and phylo-geographically inconclusive.
Currently, we do not know how cholera entered Kenya but the
fact that we were able to identify two sub-clades and some
possible travel linked outliers on the V. cholerae El Tor tree
indicates that there may have been multiple and perhaps on
going introductions of this disease into the country. Further
epidemiological and phylogenetic analysis will be required to
establish any of these possibilities. However, we know that
cholera has the potential to spread globally and jump from
region to region. Comparisons with similar phylogenetic studies
reported in other regions will be useful in defining how the
disease is evolving [2,30-32].
Using this geophylogenetic analysis we are also able to
speculate about how cholera is spreading and persisting within
Kenya as our approaches are applicable to any potential
outbreak or region and have a more general utility. For
example, the geographical and temporal distribution of isolates
of clade KSC-2 shows correlation with the previous proposals
that busy highway connecting the Indian Ocean coastal towns
to the Lake Victoria region plays an important role in
transmission during epidemic outbreaks [8].
Assembly and detailed comparison of genomes
For each isolate we performed de novo assemblies on the
short read data and manually compared these assemblies
against the N16961 reference genome. We also catalogued all
the genomic islands found in the Kenyan isolates (see Table
S3). All of the Kenyan O1 El Tor isolates possessed the Vibrio-
associated Seventh Pandemic Islands known as VSP-1 and 2
and members of the R391 family ICE/SXT multiple antibiotic
resistance cassettes. With three exceptions, all non-O1 isolates
lacked classic virulence related elements such as VPI-1, VPI-2,
VSP-1, VSP-2 and CTX. The three exceptions were
KNE056B_2, KNE17 and KNE150. KNE056B_2 and KNE17
possessed CTX and VPI-1, whereas KNE056B_2 also
possessed VPI-2. Of note, KNE150 carried R391-ICE inserted
into the peptide release chain factor-3 gene (prfC-3), the site
specific for the insertion of SXT [32]. Uniquely, every isolate in
the Kenyan clades KSC-1 and KSC-2 harboured a 4 gene
(VC0495-VC0498) deletion in the VSP-2 island. Also,
consistent with previous findings, the small number of Kenyan
wave three isolates that did not cluster within the exclusive
Kenyan clade possessed an 18 gene (VC0495-VC0516)
deletion characteristic of the South Asian isolates with which
they clustered.
All the Kenyan isolates that mapped within wave three of the
V. cholerae El Tor lineage harboured the R391-ICE/SXT
element associated with antibiotic resistance, correlating with
their resistance phenotype. This is consistent with data
obtained from analysis of V. cholerae outbreak isolates from a
previous study [33]. Clearly our data shows that antibiotic
resistance is phenotypically expressed in both the
environmental and clinical V. cholerae isolates. Interestingly,
with the exception of two isolates, the other Kenyan clinical
samples have an identical antibiotic resistance profile whereas
the samples collected from the environmental sources had
varied resistance profiles irrespective of where they clustered
in the phylogenetic tree. We do know that many of these
resistance determinants are associated with the STX elements
and that these are hot spots for recombinogenic activity within
V. cholerae, likely providing a mechanism for more rapid
evolution of resistance.
When we analysed the ctxB gene type for each sequenced
isolate, with the exception of KNE231 and KNE241 that
harboured the ctxB-3b gene [14], all other Kenyan O1 El Tor
isolates harboured the ctxB-3 toxin allele [14]. Interestingly, the
non-O1 environmental isolates, KNE056B_2 and KNE17,
harboured an identical ctxB gene, which displayed 14 SNP
differences to the reference El Tor ctxB gene. To our
knowledge this is the first time a ctxB gene with this sequence
type has been identified in non-O1/O139 V. cholerae.
Database searches revealed that the closest match to this
novel ctxB gene was found in a non-O1 environmental isolate
J31W reported from Argentina in 2009 (Genbank accession
FJ748608), which differs by a single base pair to these Kenyan
isolates at position 282. The ctxB gene of J31W, in contrast,
has the same sequence as the El Tor reference N16961 ctxB
at this position. The alignment showing the ctxB genes of
N16961, KNE056B_2, KNE17 and J31W is shown in Figure
S2.
Conclusion
We have used a combination of whole genome sequencing,
phylogenetic analysis and phenotyping to define a unique set
of V. cholerae circulating in the environment or causing clinical
cholera in Kenya. Kenya can arguably be regarded as an
exemplar country for the sub-Saharan region and a model for
their association with cholera. Our data clearly shows that
many environmental V. cholerae isolates are phylogenetically
distinct from the monophyletic seventh pandemic lineage of V.
cholerae El Tor. However, we identified multiple V. cholerae O1
isolates from environmental samples that firmly mapped onto
the V. cholerae El Tor seventh pandemic lineage, indicating
potential contamination of aquatic habitats by human activities.
Importantly, this suggests that the levels of environmental
contamination by potentially pathogenic V. cholerae O1 El Tor
are significant and a likely source of human infection. We were
able to assign the Kenyan lineages into two sub-clades that
may have entered the region independently. The clade specific
Vibrio cholerae in Kenya
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signatures and the phylogenetic position of the O1 El Tor
isolates outside the exclusive Kenyan clade strengthen the
travel and transmission link of these cases to South Asia.
Hence, it would be worth following the future outbreaks to
determine if these sporadic isolates establish themselves in
Kenya and elicit new outbreaks. Finally, we observed a
correlation of antibiotic resistance pattern and source of sample
suggesting that the pool of resistance determinants circulating
within the phylogenetically distinct environment V. cholerae and
those of the El Tor lineage in Kenya may be evolving at least in
part independently. However, as such determinants
predominantly reside within mobile STX type elements, which
are hyper-recombinogenic, there is potential for genetic
exchange between these reservoirs.
Supporting Information
Figure S1.  Map of Kenya showing sites as red dots where
the study isolates of V. cholerae were obtained.
(TIF)
Figure S2.  Clustal X 2.1 multiple nucleotide sequence
alignment showing the ctxB sequences of KNE17,
KNE056B, J31W and N16961 aligned using clustal X. The
base positions with * indicate a match and those with a gap
indicate a mismatch.
(TIF)
Table S1.  Clinical isolates and their antimicrobial
susceptibility patterns.
(XLSX)
Table S2.  Environmental isolates and their antimicrobial
susceptibility patterns.
(XLSX)
Table S3.  Non-O1/O139 Kenyan Environmental isolates
and the genomic islands found in this study.
(XLSX)
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